MARTIN SCHUH
MARTIN SCHUH is named as a lobbyist in 5 lobbying reports we hold, filed by 1 registrant for 5 clients.
Earlier government jobs, as reported
A lobbying report lists each lobbyist's covered positions: jobs in Congress or the executive branch that the law asks a lobbyist to disclose. Each line is copied as a report states it.
No report we hold lists a covered position for MARTIN SCHUH.
Registrants and clients
- EMERGENT STRATEGIES · 5 reports
Clients: CALIBER FINANCIAL SERVICES; CREDIT.COM (FORMERLY KNOWN AS PROGREXION ASG); LEXINGTON LAW; LIFE360; PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION.
Bills named where this lobbyist is listed, and how the House and the Senate voted
12 bills named in these reports. None of them became law in our record, so no recorded vote is shown. A lobbying report names the houses of Congress and the agencies the lobbyists contacted. It does not say which members or staff they met.
| Bill | Status | How the House and the Senate voted |
|---|---|---|
| H.R. 306ESCRA Act | Introduced | No recorded vote in our record |
| H.R. 2214DRUG Act | Introduced | No recorded vote in our record |
| H.R. 3209App Store Freedom Act | Introduced | No recorded vote in our record |
| H.R. 4317PBM Reform Act of 2025 | Introduced | No recorded vote in our record |
| H.R. 8413SECURE Data Act | Introduced | No recorded vote in our record |
| S. 864HELP Copays Act | Introduced | No recorded vote in our record |
| S. 927Protecting Pharmacies in Medicaid Act | Introduced | No recorded vote in our record |
| S. 1967PROTECT Act of 2025 | Introduced | No recorded vote in our record |
| S. 2153Open App Markets Act | Introduced | No recorded vote in our record |
| S. 2513OTC Monograph Drug User Fee Transparency Act | Introduced | No recorded vote in our record |
| S. 4144ESCRA Act | Introduced | No recorded vote in our record |
| S. 4746American Innovation and Choice Online Act | Introduced | No recorded vote in our record |
Issues named: Financial Institutions/Investments/Securities (3), Computer Industry (1), Consumer Issues/Safety/Products (1), Defense (1), Pharmacy (1).
Every report
| Client | Registrant | Kind, as filed | Posted | Report |
|---|---|---|---|---|
| PHARMACEUTICAL CARE MANAGEMENT ASSOCIATIONPharmacy | EMERGENT STRATEGIES | 2nd Quarter - Report | The report on LDA.gov | |
| LEXINGTON LAWFinancial Institutions/Investments/Securities | EMERGENT STRATEGIES | 2nd Quarter - Report | The report on LDA.gov | |
| LIFE360Computer Industry, Consumer Issues/Safety/Products | EMERGENT STRATEGIES | 2nd Quarter - Report | The report on LDA.gov | |
| CREDIT.COM (FORMERLY KNOWN AS PROGREXION ASG)Financial Institutions/Investments/Securities | EMERGENT STRATEGIES | 2nd Quarter - Report | The report on LDA.gov | |
| CALIBER FINANCIAL SERVICESFinancial Institutions/Investments/Securities, Defense | EMERGENT STRATEGIES | 2nd Quarter - Report | The report on LDA.gov |
Campaign gifts this lobbyist reported
Lobbyists and registrants report their political contributions twice a year (form LD-203). We hold these reports only for contributions to the campaign committees of members who sponsored or cosponsored a bill named in a lobbying report. Any other contribution: Not checked yet.
No contribution report we hold lists a gift from this filer.
Where this comes from
Lobbying Disclosure Act reports (LD-2), LDA.gov. We save our own copy of each page of LDA.gov's list of reports before we read it. These pages were built from our copies on .
2026-Q2: every page of LDA.gov's list saved and read.
A lobbying report states the registrant's income from the client (a lobbying firm) or its own lobbying expenses (an organization lobbying for itself), for the whole quarter and every issue together. A report of less than $5,000, or of no lobbying activity, states no figure. It is not the amount spent on one bill.
Senate Office of Public Records cannot vouch for the data or analyses derived from these data after the data have been retrieved from LDA.gov.